Press Releases - News for BioHouston

The top 50 press releases in our database are displayed below.

49 Record(s) Found. Displaying Page 1:

1 2 3 [Next >>]

Melding Wi-Fi with digital TV 'white space'
Release Date: 2-Sep-10 Author or Contact:
HOUSTON -- (Sept. 2, 2010) -- Rice University researchers have won a $1.8 million federal grant for one of the nation's first, real-world tests of wireless communications technology that uses a broad spectral range -- including dormant broadcast television channels -- to deliver free, high-speed broadband Internet service. The five-year project calls for Rice and Houston nonprofit Technology For All (TFA) to add "white space" technology ...
Click to read Melding Wi-Fi with digital TV 'white space'

Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions
Release Date: 30-Aug-10 Author or Contact: Dominik Werner
Basel, Switzerland, 30 August 2010 - Lonza enters the viral based-manufacturing market today with its purchase of Vivante GMP Solutions, Inc. The acquisition advances Lonza's strategy to broaden its biologics custom service offering for the growing viral vaccine and gene therapy markets. Based in Houston, Texas, Vivante is a custom manufacturing organization dedicated to producing GMP viral-based therapeutics. The ...
Click to read Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions

Tech startups hope to fight cancer
Release Date: 28-Aug-10 Author or Contact:
Houston is known for energy, but the city is also building a budding technology sector. The world's oil capital is home to scores of hopeful entrepreneurs developing new Web sites, software, medical devices, clean technologies and other innovations. Research at the Texas Medical Center, NASA, local universities and in the energy industry, for example, has given birth to new ventures. Here's one of an occasional set of snapshots ...
Click to read Tech startups hope to fight cancer

Evolution writ small
Release Date: 25-Aug-10 Author or Contact:
HOUSTON -- (Aug. 25, 2010) -- A unique experiment at Rice University that forces bacteria into a head-to-head competition for evolutionary dominance has yielded new insights about the way Darwinian selection plays out at the molecular level. An exacting new analysis of the experiment has revealed precisely how specific genetic mutations impart a physical edge in the competition for survival. The new research, which could lead to more ...
Click to read Evolution writ small

UTHealth neuroscientist wins prominent NIH Director�s Pioneer Award
Release Date: 24-Aug-10 Author or Contact:
HOUSTON - (Aug. 24, 2010) - Valentin Dragoi, Ph.D., an associate professor of neurobiology and anatomy at The University of Texas Health Science Center at Houston (UTHealth), is one of 17 researchers to win a 2010 National Institutes of Health Director's Pioneer Award. The award supports scientists who propose revolutionary, high-impact approaches to major challenges in biomedical and behavioral research. Dragoi, who is proposing ...
Click to read UTHealth neuroscientist wins prominent NIH Director�s Pioneer Award

The Porcine microRNAome is Revealed
Release Date: 19-Aug-10 Author or Contact:
Houston(August 19, 2010) Researchers from LC Sciences LLC and a collaboration of Universities1 have established a porcine microRNAome, a complete catalog of all microRNAs expressed in the species Sus scrofa2. MicroRNAs (miRNAs) are small regulatory RNA molecules known to control a wide array of cellular functions such as growth and development and whose dysregulation has been associated with disease. The findings of this study lay the ...
Click to read The Porcine microRNAome is Revealed

Mother of all humans lived 200,000 years ago
Release Date: 17-Aug-10 Author or Contact:
HOUSTON -- (Aug. 17, 2010) -- The most robust statistical examination to date of our species' genetic links to "mitochondrial Eve" -- the maternal ancestor of all living humans -- confirms that she lived about 200,000 years ago. The Rice University study was based on a side-by-side comparison of 10 human geneticmodels that each aim to determine when Eve lived using a very different set of assumptions about the way humans migrated, ...
Click to read Mother of all humans lived 200,000 years ago

Pharm-Olam Ranked Sixth Among 300,000 Companies in Ukraine
Release Date: 17-Aug-10 Author or Contact:
HOUSTON, TEXAS August 17, 2010. Pharm-Olam International Ltd. and MB Quest LLC, a member of the Pharm-Olam International Group, a multi-national full service CRO to pharmaceutical and biotech industries announce that MBQ Ukraine was published in the Ukrainian Chamber of Commerce and Industry Catalogue as ranked sixth among 300,000 companies. The ranking was based on 2009 financial statements submitted to Ukraine ...
Click to read Pharm-Olam Ranked Sixth Among 300,000 Companies in Ukraine

Luminex Donates Company's First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
Release Date: 17-Aug-10 Author or Contact:
AUSTIN, Texas, Aug. 17 /PRNewswire-FirstCall/ -- Luminex Corporation (NASDAQ:LMNX) , the worldwide leader in multiplexed solutions, today announced it has donated the first commercial unit of its newly launched MAGPIX® instrument to Professor Peter Siba and his scientific team at the Papua New Guinea Institute of Medical Research. The instrument will be used onsite in Papua New Guinea to progress malaria research led by Dr. Peter ...
Click to read Luminex Donates Company's First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research

Telltale signs of bioterror
Release Date: 16-Aug-10 Author or Contact:
HOUSTON -- (Aug. 16, 2010) -- Researchers at Rice University have won federal support to develop a genomic test that can quickly determine whether a disease outbreak is caused by a natural pathogen or one that was grown in a lab by terrorists. The three-year grant -- Rice's first from the Defense Threat Reduction Agency -- is designed to provide homeland security and public health officials with the tools they need to quickly ...
Click to read Telltale signs of bioterror

A river flipped: humans trump nature on Texas river
Release Date: 16-Aug-10 Author or Contact:
HOUSTON -- (Aug. 16, 2010) -- A new study by geochemists at Rice University finds that damming and other human activity has completely obscured the natural carbon dioxide cycle in Texas' longest river, the Brazos. "The natural factors that influence carbon dioxide cycling in the Brazos are fairly obvious, and we expected the radiocarbon signature of the river to reflect those influences," said study co-author Caroline Masiello, ...
Click to read A river flipped: humans trump nature on Texas river

A river flipped: humans trump nature on Texas river
Release Date: 16-Aug-10 Author or Contact:
HOUSTON -- (Aug. 16, 2010) -- A new study by geochemists at Rice University finds that damming and other human activity has completely obscured the natural carbon dioxide cycle in Texas' longest river, the Brazos. "The natural factors that influence carbon dioxide cycling in the Brazos are fairly obvious, and we expected the radiocarbon signature of the river to reflect those influences," said study co-author Caroline Masiello, ...
Click to read A river flipped: humans trump nature on Texas river

Repros Therapeutics Granted Key Patent for Androxal�
Release Date: 11-Aug-10 Author or Contact:
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqCM:RPRX) today announced the US Patent and Trademark office has issued U.S. Patent No. 7,759,360 for Androxal®, the Company's lead program for the treatment of low testosterone in men. This patent specifically claims methods and materials for the treatment of testosterone deficiency in men with secondary hypogonadism. Repros has over 35 issued or pending US and ...
Click to read Repros Therapeutics Granted Key Patent for Androxal�

San Antonio Community Hospital Converts to Masimo rainbow Technology for Advanced Noninvasive Patient Monitoring Capabilities
Release Date: 10-Aug-10 Author or Contact:
IRVINE, Calif., Aug. 10 /PRNewswire-FirstCall/ -- San Antonio Community Hospital (SACH) in Upland, California, and Masimo (NASDAQ:MASI) , the inventor of Masimo rainbow Pulse CO-Oximetry(TM), Masimo rainbow Acoustic Monitoring(TM), and Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry, today jointly announced the completion of San Antonio Community Hospital's system-wide conversion to Masimo rainbow technology. The ...
Click to read San Antonio Community Hospital Converts to Masimo rainbow Technology for Advanced Noninvasive Patient Monitoring Capabilities

BioHouston Announces Keynote Speakers of 2010 Texas Life Science Conference
Release Date: 10-Aug-10 Author or Contact:
HOUSTON, Texas -BioHouston announced today the keynote speakers for the 2010 Texas Life Science Conference. The company would like to welcome Dennis Purcell and Paul LaViolette to the agenda. This year's conference will be held in Houston, TX November 10-12, 2010. The Texas Life Science Conference is Texas' premier venture conference, the most comprehensive showcase of cutting edge research and innovative entrepreneurs in the ...
Click to read BioHouston Announces Keynote Speakers of 2010 Texas Life Science Conference

Repros Therapeutics Inc. Reports Second Quarter 2010 Financial Results
Release Date: 9-Aug-10 Author or Contact:
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqCM: RPRX) today announced financial results for the second quarter ended June 30, 2010. Financial Results Net loss for the three month period ended June 30, 2010, was ($1.3) million or ($0.04) per share as compared to a net loss of ($8.9) million or ($0.59) per share for the same period in 2009. The net loss for the six month period ended June 30, 2010, was ($2.4) ...
Click to read Repros Therapeutics Inc. Reports Second Quarter 2010 Financial Results

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Second Quarter Financial Results
Release Date: 9-Aug-10 Author or Contact:
THE WOODLANDS, Texas, Aug. 9 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated the progress of its drug development programs and reported financial results for the three and six months ended June 30, 2010. "The newly-obtained data from our Phase 2a study in diabetes has provided insight into the ...
Click to read Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Second Quarter Financial Results

Repros Receives Positive Feedback from the Division of Reproductive and Urologic Products for Androxal� in the Treatment of Hypogonadal Men Wishing to Preserve Fertility
Release Date: 9-Aug-10 Author or Contact:
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqCM:RPRX) today announced that the Company has received positive written feedback from the FDA (the "Agency") regarding the Company's drug candidate Androxal®. The Agency concurred with Repros' indication statement for the use of Androxal in the treatment of secondary hypogonadism in men wishing to preserve fertility. "We recommend enrolling only those subjects with ...
Click to read Repros Receives Positive Feedback from the Division of Reproductive and Urologic Products for Androxal� in the Treatment of Hypogonadal Men Wishing to Preserve Fertility

Cornerstone Pharmaceuticals Adds New Clinical Trial Site for the Evaluation of Its First-in-Class Anti-Cancer Agent CPI-613
Release Date: 5-Aug-10 Author or Contact:
CRANBURY, N.J., Aug. 5 /PRNewswire/ -- Cornerstone Pharmaceuticals, Inc. today announced the addition of Mary Crowley Cancer Research Centers to its roster of sites for its ongoing Phase I/II clinical trials of its first-in-class anti-cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells. "As one of the ...
Click to read Cornerstone Pharmaceuticals Adds New Clinical Trial Site for the Evaluation of Its First-in-Class Anti-Cancer Agent CPI-613

ION Reports Improved Second Quarter 2010 Results
Release Date: 4-Aug-10 Author or Contact:
HOUSTON, Aug. 4 /PRNewswire-FirstCall/ -- ION Geophysical Corporation (NYSE: IO) today reported second quarter 2010 revenues of $75.4 million, resulting in net income of $1.1 million, or $0.01 per diluted share. In the second quarter of 2009, ION's net loss was ($16.6) million, or ($0.16) per share, on revenues of $89.3 million. Bob Peebler, ION's Chief Executive Officer, said, "We were pleased to regain profitability, ...
Click to read ION Reports Improved Second Quarter 2010 Results

1 2 3 [Next >>]

Contact Us | Site Map |

| OPML | Search This Site | Home
Schipul Web Design | Houston Social Media | Tendenci� Content Management Software | Privacy | Terms and Conditions